Skip to content
Insider tapeLive · 5:07 PM ET
My stocks

Jason Pitofsky

At a glance: Jason Pitofsky is Svp Controller at Regeneron Pharmaceuticals (REGN). Their latest SEC Form 4, filed Nov 6, 2026, reported a sale of $412K. On file: 0 purchase lines ($0) and 20 sale lines ($5.7M).

Disclosed holdings: about $4.0M of REGN stock: 4,272 shares (including shares held indirectly, e.g. through a trust or fund) reported on their latest Form 4 (filed Nov 6, 2026), valued at the Nov 19, 2026 close of $932.53. This counts only REGN shares reported to the SEC; it leaves out cash, other investments, options and unvested awards, so it is not total net worth.

Svp Controller at Regeneron Pharmaceuticals, Inc. (REGN); Vp Controller at Regeneron Pharmaceuticals, Inc. (REGN)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $5.7M

Jason Pitofsky's InsiderPrint

20 trades from SEC Form 4 filings, 2025 to 2026, drawn as one fingerprint.

InsiderPrint of Jason Pitofsky: 20 trades, 2025 to 20262025: 0 buys, 1 sale2026: 0 buys, 19 sales

Reading this print: Almost only sells, trading about 20 times a year, typically $170K a trade; trades in the same month most years.

  • Bump outward: a purchase (0)
  • Dent inward: a sale (20)
  • One ring per year, oldest in the middle, Jan at the top going clockwise. Bigger bumps mean more dollars.

Insiders with a similar print

  1. Bruce N. JacobsCFO · KYMR · 99% match
  2. Christopher A. KroegerCEO · MPLT · 98% match
  3. Jeremy G. ChadwickCOO · KYMR · 98% match
  4. Markus GloecklerCTO · FSLR · 98% match
  5. William John SiboldCEO, President · MDGL · 98% match

Matched on seven traits of each insider's trading pattern (buy share, pace, typical size, planned sales, seasonality, buying after drops, number of companies). Pattern matching on public filings; history, not a prediction.

Reported trades

Filed Stock Type Shares Price Value Since
Nov 6SEC REGNRegeneron Pharmaceuticals, Inc. Sell 4397,716 held (−5%) $939.57 $412K -0.7%
Nov 6SEC REGNRegeneron Pharmaceuticals, Inc. Sell 5757,141 held (−7%) $940.46 $541K -0.8%
Nov 6SEC REGNRegeneron Pharmaceuticals, Inc. Sell 9826,159 held (−14%) $941.58 $925K -1.0%
Nov 6SEC REGNRegeneron Pharmaceuticals, Inc. Sell 1,2154,944 held (−20%) $942.31 $1.1M -1.0%
Nov 6SEC REGNRegeneron Pharmaceuticals, Inc. Sell 5294,415 held (−11%) $943.53 $499K -1.2%
Nov 6SEC REGNRegeneron Pharmaceuticals, Inc. Sell 1084,307 held (−2%) $944.22 $102K -1.2%
Nov 6SEC REGNRegeneron Pharmaceuticals, Inc. Sell 354,272 held (−1%) $945.61 $33K -1.4%
Nov 6SEC REGNRegeneron Pharmaceuticals, Inc. Sell 179 $950.76 $170K -1.9%
Feb 11SEC REGNRegeneron Pharmaceuticals, Inc. Sell Plan 206,288 held (−0%) $775.95 $16K +20.2%
Feb 11SEC REGNRegeneron Pharmaceuticals, Inc. Sell Plan 5215,767 held (−8%) $776.43 $405K +20.1%
Feb 11SEC REGNRegeneron Pharmaceuticals, Inc. Sell Plan 3915,376 held (−7%) $777.51 $304K +19.9%
Feb 11SEC REGNRegeneron Pharmaceuticals, Inc. Sell Plan 5634,813 held (−10%) $778.35 $438K +19.8%
Feb 11SEC REGNRegeneron Pharmaceuticals, Inc. Sell Plan 2054,608 held (−4%) $779.56 $160K +19.6%
Feb 11SEC REGNRegeneron Pharmaceuticals, Inc. Sell Plan 754,533 held (−2%) $780.06 $59K +19.5%
Feb 11SEC REGNRegeneron Pharmaceuticals, Inc. Sell Plan 264,507 held (−1%) $781.37 $20K +19.3%
Feb 11SEC REGNRegeneron Pharmaceuticals, Inc. Sell Plan 374,470 held (−1%) $782.67 $29K +19.1%
Feb 11SEC REGNRegeneron Pharmaceuticals, Inc. Sell Plan 1444,326 held (−3%) $783.23 $113K +19.1%
Feb 11SEC REGNRegeneron Pharmaceuticals, Inc. Sell Plan 14,325 held (−0%) $784.66 $785 +18.8%
Feb 11SEC REGNRegeneron Pharmaceuticals, Inc. Sell Plan 534,272 held (−1%) $785.72 $42K +18.7%
Nov 10SEC REGNRegeneron Pharmaceuticals, Inc. Sell 4314,233 held (−9%) $651.43 $281K +43.2%
  • Sell

    Svp Controller Jason Pitofsky sold $16K of REGN at $775.95 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Svp Controller Jason Pitofsky sold $405K of REGN at $776.43 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Svp Controller Jason Pitofsky sold $304K of REGN at $777.51 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Svp Controller Jason Pitofsky sold $438K of REGN at $778.35 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Svp Controller Jason Pitofsky sold $160K of REGN at $779.56 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Svp Controller Jason Pitofsky sold $59K of REGN at $780.06 — pre-scheduled 10b5-1 plan sale.

Follow Jason Pitofsky

Get one email when Jason Pitofsky files a new purchase or sale. Free.

At most one email a day about Jason Pitofsky, plus the free Monday email. Already subscribed? Use the same email to add them. Unsubscribe anytime. Facts from public filings, not advice.